Back to Browse Journals » Clinical Interventions in Aging » Volume 2 » Issue 4

The many faces of testosterone

Authors Jerald Bain

Published 15 January 2008 Volume 2007:2(4) Pages 567—576


Jerald Bain

Department of Medicine, Department of Obstetrics and Gynecology, University of Toronto, Ontario, Canada; Division of Endocrinology and Metabolism, Mount Sinai Hospital, Toronto, Ontario, Canada

Abstract: Testosterone is more than a “male sex hormone”. It is an important contributor to the robust metabolic functioning of multiple bodily systems. The abuse of anabolic steroids by athletes over the years has been one of the major detractors from the investigation and treatment of clinical states that could be caused by or related to male hypogonadism. The unwarranted fear that testosterone therapy would induce prostate cancer has also deterred physicians form pursuing more aggressively the possibility of hypogonadism in symptomatic male patients. In addition to these two mythologies, many physicians believe that testosterone is bad for the male heart. The classical anabolic agents, 17-alkylated steroids, are, indeed, potentially harmful to the liver, to insulin action to lipid metabolism. These substances, however, are not testosterone, which has none of these adverse effects. The current evidence, in fact, strongly suggests that testosterone may be cardioprotective. There is virtually no evidence to implicate testosterone as a cause of prostate cancer. It may exacerbate an existing prostate cancer, although the evidence is flimsy, but it does not likely cause the cancer in the first place. Testosterone has stimulatory effects on bones, muscles, erythropoietin, libido, mood and cognition centres in the brain, penile erection. It is reduced in metabolic syndrome and diabetes and therapy with testosterone in these conditions may provide amelioration by lowering LDL cholesterol, blood sugar, glycated hemoglobin and insulin resistance. The best measure is bio-available testosterone which is the fraction of testosterone not bound to sex hormone binding globulin. Several forms of testosterone administration are available making compliance much less of an issue with testosterone replacement therapy.
Keywords: testosterone, androgens, male hypogonadism, anabolic steroids

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Survival of women with breast cancer in central and northern Denmark, 1998–2009

Lietzen LW, Sørensen GV, Ording AG, Garne JP, Christiansen P, Nørgaard M, Jacobsen J

Clinical Epidemiology 2011, 3:35-40

Published Date: 21 July 2011

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?

Pergolizzi J, Alon E, Baron R, Bonezzi C, Dobrogowski J, Gálvez R, Jensen T, Kress H-G, Marcus MA, Morlion B, Perrot S, Treede R-D

Journal of Pain Research 2011, 4:203-210

Published Date: 21 July 2011

Role of stress fibers and focal adhesions as a mediator for mechano-signal transduction in endothelial cells in situ

Kazuo Katoh, Yumiko Kano, Shigeo Ookawara

Vascular Health and Risk Management 2008, 4:1273-1282

Published Date: 5 December 2008

Clinical challenges in the management of osteoporosis

Sheryl F Vondracek, Paul Minne, Michael T McDermott

Clinical Interventions in Aging 2008, 3:315-329

Published Date: 6 June 2008

Psychotherapeutic intervention by telephone

Erika Mozer, Bethany Franklin, Jon Rose

Clinical Interventions in Aging 2008, 3:391-396

Published Date: 6 June 2008

The development of a fear of falling interdisciplinary intervention program

Fernando Gomez, Carmen-Lucia Curcio

Clinical Interventions in Aging 2007, 2:661-667

Published Date: 15 January 2008

The osteoporotic male: Overlooked and undermanaged?

Bruno Madeo, Lucia Zirilli, Giovanni Caffagni, Chiara Diazzi, Alessia Sanguanini, et al

Clinical Interventions in Aging 2007, 2:305-312

Published Date: 15 October 2007

The management of hemophilia in elderly patients

Massimo Franchini, Annarita Tagliaferri, Pier Mannuccio Mannucci

Clinical Interventions in Aging 2007, 2:361-368

Published Date: 15 October 2007

Treatment of specific phobia in older adults

Nancy A Pachana, Rana M Woodward, Gerard JA Byrne

Clinical Interventions in Aging 2007, 2:469-476

Published Date: 15 October 2007